ArticleJournal of Cancer2025
Expression of CX3CL1 in the neoplastic lung tissue of squamous cell lung cancer.
Article in Journal of Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer has one of the highest mortality rates. Although epidermoid lung cancer is one of the most prevalent subtypes of lung cancer, no targeted therapy is currently available for this type of cancer. CX3CL1 is a chemokine that has emerged as a potential molecular target for several malignancies. Chemokines direct the migration of various cell types to the tumor and influence tumor cell behavior. To date, little information is available on the role of this chemokine in squamous cell lung cancer. Using immunofluorescence, we evaluated the expression of CX3CL1 in histological specimens of neoplastic lung tissue from squamous cell lung cancer patients. CX3CL1 was expressed in squamous neoplastic lung tissues at all grades of tumor differentiation. We found this chemokine in the cytoplasm and nucleus of non-transformed cells in the adjacent tissue, but it was infrequent in the nucleus of neoplastic cells, which could have biological relevance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.